title: Infectious disease screening of blood specimens collected post-mortem provides comparable results to pre-mortem specimens.
abstract: Serology assays for standard screening are optimised for use with sera collected from living adults and children. Because of potential changes in the vascular compartments after death, methods used for screening sera from cadaveric organ donors need to be validated before testing these specimens. Serum was separated from blood collected from cadaveric donors within 24 h of death and biochemical parameters measured to detect dilution of protein and haemolysis. In order to demonstrate if any inhibitors that might interfere with the assays were present, pre and post-mortem specimens were spiked with aliquots of human immunodeficiency virus (HIV), hepatitis C virus (HCV), hepatitis B virus (HBV), human T-cell Lymphotropic Virus (HTLV) and T. pallidum-positive sera. Comparison of serum from living subjects with serum obtained post-mortem showed that while the concentration of total protein decreased, concentrations of albumin, immunoglobulin G (IgG) and immunoglobulin M (IgM) remained unchanged. The degree of haemolysis, as measured by free haemoglobin, was within the limits accepted for the Architect analyser. Spiking of pre- and post-mortem specimens with aliquots of HIV, HCV, HBV, HTLV and T. pallidum-positive sera showed no statistical difference in the signal between pre-mortem and post-mortem results when tested on the Abbott Architect analyser. Positive results were obtained in each of a further nine subjects who had tested positive for HIV (n=1), HCV (n=8), HBV (n=1) on pre-mortem serological testing. These findings suggest that the sensitivity of the Abbott Architect serological screening tests is not significantly affected in specimens collected within 24 h of the cessation of life.
authors.affiliation: Virology Division, SEALS, Prince of Wales Hospital, Randwick, Sydney, NSW, 2031, Australia.
authors.forename: Cristina
authors.initials: C
authors.lastname: Baleriola
authors.forename: Harpreet
authors.initials: H
authors.lastname: Johal
authors.forename: Peter
authors.initials: P
authors.lastname: Robertson
authors.forename: Brendan
authors.initials: B
authors.lastname: Jacka
authors.forename: Ross
authors.initials: R
authors.lastname: Whybin
authors.forename: Peter
authors.initials: P
authors.lastname: Taylor
authors.forename: William D
authors.initials: WD
authors.lastname: Rawlinson
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001800:Blood Specimen Collection / Q000379:methods*; D002102:Cadaver; D003141:Communicable Diseases / Q000097:blood* / Q000175:diagnosis*; D015480:Deltaretrovirus Antibodies / Q000097:blood; D003710:Demography; D005260:Female; D015483:HIV Antibodies / Q000097:blood; D015488:HIV Antigens / Q000097:blood; D006510:Hepatitis B Antibodies / Q000097:blood; D006511:Hepatitis B Antigens / Q000097:blood; D018937:Hepatitis C Antibodies / Q000097:blood; D006801:Humans; D008297:Male; D008403:Mass Screening; D008875:Middle Aged; D011180:Postmortem Changes; D013587:Syphilis / Q000097:blood; D055815:Young Adult
chemical_list: D015480:Deltaretrovirus Antibodies; D015483:HIV Antibodies; D015488:HIV Antigens; D006510:Hepatitis B Antibodies; D006511:Hepatitis B Antigens; D018937:Hepatitis C Antibodies